ANGO earnings: a negative outcome, -16.7%

On October 3, 2024, AngioDynamics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -16.7% in the window around the event. It had already run +6.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.